Related Experiment Video
Updated: Jan 10, 2026

Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy
Published on: August 10, 2018
GM-CSF and specific type 2 cytokines induce CD103+ and CD301b+ cell states in cDC1s and cDC2s
Lukas Amon1, Damir Vurnek2, Anna Seichter3
1Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nürnberg, 91052 Erlangen, Germany; Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, 9052 Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, 9000 Ghent, Belgium.
Insights
Granulocyte/macrophage colony-stimulating factor (GM-CSF) drives the differentiation of conventional dendritic cells type 1 (cDC1s) and type 2 (cDC2s). CD301b+ cDC2s represent a cytokine-induced state, distinct from GM-CSF-driven cDC1s.
Area of Science:
- Immunology
- Cell Biology
Background:
- Conventional dendritic cells type 1 (cDC1s) and type 2 (cDC2s) exhibit significant heterogeneity.
- The precise origin and identity of CD301b+ cDC2s, a subset of cDC2s, remain unclear.
Purpose of the Study:
- To elucidate the developmental pathways and regulatory mechanisms governing CD301b+ cDC2s and CD103+ cDC1s.
- To investigate the roles of granulocyte/macrophage colony-stimulating factor (GM-CSF) and type 2 cytokines in cDC differentiation.
Main Methods:
- Analysis of dendritic cell progenitor differentiation in response to GM-CSF.
- Assessment of CD103 and CD301b expression in vitro and in vivo.
- Evaluation of T cell priming capacities and cytokine profiles of differentiated DCs.
Main Results:
- CD301b+ cDC2s and CD103+ cDC1s originate from pre-committed progenitors influenced by GM-CSF.
- CD103+ cDC1s differentiate via GM-CSF from pre-cDC1s, while CD301b+ cDC2s arise as cytokine-induced states.
- Both subsets display enhanced T cell priming and distinct cytokine profiles upon GM-CSF stimulation.
- GM-CSF signaling within DCs is largely dispensable for CD103/CD301b expression in vivo, except in lung DCs.
- Type 2 cytokines induce CD103 and CD301b expression ex vivo.
Conclusions:
- GM-CSF and specific type 2 cytokines are key regulators of cDC1 and cDC2 effector differentiation.
- CD301b serves as a marker for a cytokine-induced cDC2 state, clarifying cDC heterogeneity.
Abstract:
The heterogeneity of conventional dendritic cells type 1 (cDC1s) and type 2 (cDC2s) is well established, yet the identity and origin of CD301b+ cDC2s remain debated. Here, we show that CD301b+ cDC2s and CD103+ cDC1s develop from pre-committed progenitors in response to granulocyte/macrophage colony-stimulating factor (GM-CSF). While CD103+ cDC1s acquire their phenotype and functional properties through GM-CSF-driven differentiation from pre-cDC1s, CD301b+ cDC2s emerge as cytokine-induced states from DC2- and DC3-committed progenitors. CD103+ cDC1s and CD301b+ cDC2s exhibit enhanced T cell priming capacities and distinct cytokine expression profiles upon GM-CSF exposure. In vivo, DC-intrinsic GM-CSF sensing is dispensable for acquiring CD103 and CD301b expression with the notable exception of lung DCs, while specific type 2 cytokines induce CD103 and CD301b ex vivo. These findings identify GM-CSF and specific type 2 cytokines as central regulators of cDC1 and cDC2 effector differentiation and establish CD301b as a marker of a cytokine-driven cDC2 state.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

